Identifying effect modifiers of systemic hydrocortisone treatment initiated 7-14 days after birth in ventilated very preterm infants on long-term outcome: secondary analysis of a randomised controlled trial

Conclusion This secondary analysis suggests that in infants <27 weeks’ GA, systemic hydrocortisone may improve the outcome death or NDI, mainly driven by its component death. There was insufficient evidence for other selected candidate effect modifiers.

http://fn.bmj.com/cgi/content/short/109/2/159?rss=1

Source: Archives of Disease in Childhood - Fetal and Neonatal Edition - February 19, 2024 Category: Perinatology & Neonatology Authors: Halbmeijer, N. M., Sonnaert, M., Swarte, R. M., Koopman-Esseboom, C., van Stuijvenberg, M., Mulder-de Tollenaer, S., Tan, R. N. G. B., Mohns, T., Bruneel, E., Steiner, K., Kramer, B. W., Debeer, A., van Weissenbruch, M. M., Marechal, Y., Blom, H., Plaskie Tags: Original research Source Type: research